Advertisement
Canada markets open in 22 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7323
    -0.0000 (-0.00%)
     

  • CRUDE OIL

    84.31
    +0.74 (+0.89%)
     

  • Bitcoin CAD

    87,556.05
    +1,350.66 (+1.57%)
     

  • CMC Crypto 200

    1,386.53
    -10.00 (-0.72%)
     

  • GOLD FUTURES

    2,356.30
    +13.80 (+0.59%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.6860
    -0.0200 (-0.42%)
     

  • NASDAQ futures

    17,725.75
    +158.25 (+0.90%)
     

  • VOLATILITY

    15.57
    +0.20 (+1.30%)
     

  • FTSE

    8,113.90
    +35.04 (+0.43%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6831
    +0.0010 (+0.15%)
     
MARKETS LIVE BLOG:

STOCK FUTURES JUMP, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Moving Average Crossover Alert: Abeona Therapeutics (ABEO)

Zacks Equity Research
·2 min read

Abeona Therapeutics Inc. ABEO could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for ABEO broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.

This has already started to take place, as the stock has moved lower by 7.8% in the past four weeks. And with the recent moving average crossover, investors have to think that more unfavorable trading is ahead for ABEO stock.

If that wasn’t enough, ABEO isn’t looking too great from an earnings estimate revision perspective either. It appears as though many analysts have been reducing their earnings expectations for the stock lately, which is usually not a good sign of things to come.

Consider that in the last 30 days, 1 estimate has been reduced, while none have moved higher. Add this in to a similar move lower in the consensus estimate, and there is plenty of reason to be bearish here.

ADVERTISEMENT

That is why we currently have a Zacks Rank #5 (Strong Sell) on this stock and are looking for it to underperform in the weeks ahead. So, either avoid this stock or consider jumping ship until the estimates and technical factors turn around for ABEO. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Bitcoin, Like the Internet Itself, Could Change Everything

Blockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the “Internet of Money” and predict it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree we’re still in the early stages of this technology, and as it grows, it will create several investing opportunities.

Zacks’ has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly.

See 3 crypto-related stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Abeona Therapeutics Inc. (ABEO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research